The Marble Center for Cancer Nanomedicine is turning 10! Since 2016, the Marble Center has been leveraging advances in miniaturization to tackle grand challenges in cancer detection, treatment and monitoring. Join us as we celebrate Center research, highlight successes, and preview developments guiding the future of cancer nanomedicine.
Speakers include Marble Center director Sangeeta Bhatia and Koch Institute director Matthew Vander Heiden, Center member Bob Langer, and a panel of Center alumni and collaborators bringing nanomedicine applications to the market.
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.
